• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Thrivelab Launches Affordable Virtual Menopause Care for Women in New Jersey

by Jasmine Pennic 10/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Thrivelab, a provider of hormone health services, is addressing the women’s health crisis by launching accessible and affordable virtual menopause care in New Jersey. 

– Thrivelab aims to bridge the gap in menopause care and provide relief for women experiencing hormonal imbalances.

Addressing a Critical Need

A staggering 80% of women between the ages of 35 and 70 suffer from symptoms of hormone imbalance, yet many remain untreated due to a lack of awareness and access to care. Thrivelab’s virtual platform tackles this issue head-on, providing convenient and affordable solutions for women across New Jersey.

Thrivelab’s Comprehensive Approach

Thrivelab offers personalized, evidence-based hormone therapy and support for a wide range of conditions linked to hormonal imbalances, including:

  • Menopause and Perimenopause: Addressing common symptoms such as hot flashes, mood swings, sleep disturbances, and low energy.
  • Hormonal Conditions: Providing solutions for conditions like obesity, diabetes, PCOS, and post-hysterectomy side effects.
  • Mental Health: Supporting women experiencing depression and anxiety related to hormonal imbalances.

Accessible Virtual Care

Thrivelab’s virtual model allows women to access specialized care from the comfort of their homes. Through personalized consultations, the company’s team of experts, including hormone specialists, nutritionists, and lifestyle coaches, develop tailored treatment plans for each patient.

Symptoms Addressed by Thrivelab:

  • Weight gain
  • Mood swings
  • Sleep issues
  • Hot flashes
  • Low energy
  • Hair loss
  • Irregular menstruation
  • Brain fog
  • Fatigue
  • Brittle nails
  • Hormonal acne
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |